Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
TC BioPharm (Holdings) PLC Sponsored ADR (TCBPY) had Stock-Based Compensation of $1.30M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-15.53M |
|
-- |
|
-- |
|
$16.32M |
|
$-16.32M |
|
$-0.05M |
|
$-16.36M |
|
$-16.36M |
|
$-15.53M |
|
$-15.53M |
|
$-15.53M |
|
$-15.53M |
|
$-16.32M |
|
$-15.76M |
|
0.09M |
|
0.09M |
|
$-153.36 |
|
$-153.36 |
|
| Balance Sheet Financials | |
$7.38M |
|
$1.22M |
|
$3.26M |
|
$10.64M |
|
$5.30M |
|
$1.50M |
|
$1.50M |
|
$6.80M |
|
$3.85M |
|
$3.25M |
|
$3.85M |
|
0.64M |
|
| Cash Flow Statement Financials | |
$-16.06M |
|
$-0.12M |
|
$14.65M |
|
$3.15M |
|
$1.55M |
|
$-1.59M |
|
|
Stock-Based Compensation |
$1.30M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.39 |
|
-- |
|
-- |
|
0.28 |
|
0.50 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-16.14M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-403.84% |
|
-477.87% |
|
-145.93% |
|
-290.72% |
|
$6.03 |
|
$-170.99 |
|
$-170.12 |
|